Alerte De Sécurité sur Trade name: Minimed 640G Insulin Pump. Technical Name: Infusion Pump. ANVISA registration number: 10339190656. Class of risk: III. Affected Model: MMT-1712K; MMT-1752; MMT-1752K; MMT-1752KBP; MMT-1752WWK; MMT-1752WWKA. Serial number affected: See distribution map

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Medtronic Comercial Ltda; Medtronic Puerto Rico Operations Co..

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
  • Date
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    All recommendations for pump users are outlined in the Pump User Letter issued by the company. If you wish to notify technical complaints and adverse events use the following channels: Notivisa: Notices of adverse events (AE) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link Additional information: - Date of identification of the problem by the company: 02/13/2018 - Date of notification notice for Anvisa: 02/20/2018 The company that owns the affected product is responsible for contacting its customers in a timely manner. to ensure the effectiveness of the Field Action in progress. It stands out the joint responsibility of the distribution chain and use of health products in maintaining its quality, safety and efficacy, as well as the effectiveness of the Field Action, expressed by RDC 23/2012: "(...) Art 2 ° A holder of registration of health product is the holder of the registration / registration of health product with Anvisa. Single paragraph. The registration holder, as well as other agents involved from the production to the use of the product, or discarding it when applicable, are jointly and severally responsible for maintaining the quality, safety and efficacy of the health products to the final consumer. Art. 12 Distributors of health products shall forward to the registration holder, in a timely manner, the distribution map and other information requested for the notification and execution of field actions. (...) "
  • Cause
    Through the company's global quality and safety monitoring system, the manufacturer has received infusion pump-related complaints where a button may become difficult to press or a button may appear to be pressed and held in place. one of these complaints led to a hyperglycemic event without hospitalization; these complaints occurred outside brazil. if a user is traveling by plane or engaged in an activity where ambient pressure around the device increases or decreases rapidly, which would cause the pump buttons to become trapped or render them irresponsible, it could lead to a hypoglycemic event or hyperglycemic. the keyboard buttons on the minimed 640g insulin pump may have this rare and temporary condition in which they may temporarily lock up, rendering it irresponsible, this may occur when the atmospheric pressure around the pump increases or decreases rapidly, occurring more frequently when traveling during takeoff or landing. according to the manufacturer, if this happens, in most cases the user may not even notice the problem, because the pump will solve this condition alone.
  • Action
    Field Action Code FA767 Phase II triggered under the responsibility of the company Medtronic Comercial Ltda. It will communicate to customers who have purchased the product.


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source